Literature DB >> 29744004

Gadolinium-Induced Nephrogenic Systemic Fibrosis.

Anita H Shah1, Juan Jose Olivero1.   

Abstract

The column in this issue is supplied by Anita H. Shah, M.D., and Juan Jose Olivero, M.D. Dr. Shah obtained her medical degree at The University of Texas Medical Branch in Galveston and is currently an internal medicine resident at Houston Methodist Hospital. Dr. Olivero is a nephrologist at Houston Methodist Hospital and a member of the hospital's Nephrology Fellowship Training Program. He obtained his medical degree from the University of San Carlos School of Medicine in Guatemala, Central America, and completed his residency and nephrology fellowship at Baylor College of Medicine in Houston, Texas.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29744004      PMCID: PMC5935203          DOI: 10.14797/mdcj-13-3-172

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN: 1947-6108


  5 in total

Review 1.  Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy).

Authors:  Anjela Galan; Shawn E Cowper; Richard Bucala
Journal:  Curr Opin Rheumatol       Date:  2006-11       Impact factor: 5.006

Review 2.  Safety and technique of ferumoxytol administration for MRI.

Authors:  Shreyas S Vasanawala; Kim-Lien Nguyen; Michael D Hope; Mellena D Bridges; Thomas A Hope; Scott B Reeder; Mustafa R Bashir
Journal:  Magn Reson Med       Date:  2016-02-18       Impact factor: 4.668

Review 3.  Current status of gadolinium toxicity in patients with kidney disease.

Authors:  Mark A Perazella
Journal:  Clin J Am Soc Nephrol       Date:  2009-02       Impact factor: 8.237

4.  Gadolinium-associated nephrogenic systemic fibrosis.

Authors:  Jeffrey D Schlaudecker; Christopher R Bernheisel
Journal:  Am Fam Physician       Date:  2009-10-01       Impact factor: 3.292

Review 5.  Gadolinium-Induced Fibrosis.

Authors:  Derrick J Todd; Jonathan Kay
Journal:  Annu Rev Med       Date:  2016       Impact factor: 13.739

  5 in total
  1 in total

Review 1.  Nephrogenic Systemic Fibrosis as a Complication after Gadolinium-Containing Contrast Agents: A Rapid Review.

Authors:  Sandra Lange; Wioletta Mędrzycka-Dąbrowska; Katarzyna Zorena; Sebastian Dąbrowski; Daniel Ślęzak; Anna Malecka-Dubiela; Przemysław Rutkowski
Journal:  Int J Environ Res Public Health       Date:  2021-03-15       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.